在意大利北部直接使用口服抗凝剂的预测因素:基于人口的研究
Luisa Ojeda-Fernández1, Greta Agostini1, Anna Zanovello1
1Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.
Pharmacoepidemiology and drug safety
|December 16, 2025
概括
直接口服抗凝剂 (DOAC) 的处方模式因患者的特征和并发症而异. 阿皮克萨班越来越多地使用,而达比加特兰使用量下降,在现实实践中观察到的5.6%的切换率.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 现实世界的证据 现实世界的证据
背景情况:
- 直接口服抗凝剂 (DOAC) 广泛用于血栓预防.
- 关于对比和选择或切换DOAC的原因的数据有限.
研究的目的:
- 在意大利北部的一个未经选择的人群中调查DOAC使用模式.
- 为了确定DOAC处方和切换行为的预测因素.
主要方法:
- 伦巴第地区 (2019-2022) 的卫生行政数据分析.
- 包括45岁以上开始DOAC治疗的受试者.
- 后勤回归以确定处方预测因素;评估切换率.
主要成果:
- 阿皮克萨班使用量增加 (29.0%至34.3%),而达比加特兰使用量减少 (20.7%至11.5%).
- 年龄较大和女性性别预测EDOXABAN使用;并发症影响了APIXABAN,DABIGATRAN和RIVAROXABAN的选择.
- 患有出血史的患者更喜欢阿皮克萨班和埃多克萨班;整体DOAC切换率为5.6%.
结论:
- 现实世界的数据揭示了影响DOAC选择和切换的因素.
- 研究结果提供了对临床医生对DOACs行为的见解.
- 需要进一步的研究来为临床实践指南提供信息.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Bias in Epidemiological Studies
1.2K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.2K
Therapeutic Drug Monitoring: Affecting Factors
175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
270
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
270


